Abstract
To assess the clinical characteristics of metastatic testicular germ cell tumour, response to chemotherapy and outcome of salvage surgery for residual mass were analyzed. Patients with complete response were carefully watched. Salvage surgery was performed in 14 patients after chemotherapy. Resected specimens showed 7 necrosis/fibrosis, 5 teratoma, 1 cancer, and 1 benign schwannoma. Only necrosis/fibrosis was found in cases without teratoma in the primary tumour. Existence of teratomatous elements in a primary tumour suggests that cancer or teratoma is present in the residual tumour. Furthermore, tumour reduction rate could not predict their presence in resected specimens.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Einhorn, L. H., Donohue, J. P.: Cis-diamminedichloroplatinum, vinblastine and bleomycin chemotherapy in disseminated testicular cancer.Ann. Intern. Med., 87, 293 (1977).
Pizzocaro, G., Pas, I. M., Salvioni, R.: Cisplatin and etoposide salvage therapy and resection of the residual tumor in pretreated germ cell testicular cancer.Cancer, 56, 2399 (1985).
Vugrin, D., Herr, H. W., Whitmore, W. F. Jr.: VAB-6 combination chemotherapy for disseminated cancer of the testis.Ann. Intern. Med., 95, 59 (1981).
Donohue, J. P., Rowland, R. G.: The role of surgery in advanced testicular cancer.Cancer, 54, 2716 (1984).
Tsukamoto, T., Kumamoto, E., Miyao, N., Hirose, T., Takagi, Y.: Testicular cancer: Treatments for metastases.Hinyokigeka, 2, 987 (1989).
Suzuki, K., Ozawa, M., Nakazato, H.: Clinical study on 78 cases of testicular tumor.Acta Urol. Jpn., 41, 197 (1995).
Jinbo, S., Shimizu, T., Ono, Y., Inaba, S.: Clinical studies on autologous bone marrow transplantation in testicular cancer.Kitakantoizaku, 41, 723 (1991).
Pecham, M.: Testicular cancer.Rev. Oncol., 1, 439 (1988).
Kubota, Y., Kurita, M., Saitou, Y.: A case of aortoduodenal fistula after retroperitoneal lymph node dissection in testicular tumor.Kitakantoizaku, 40, 637 (1990).
Einhorn, L. H.: VP-16 plus ifosfamide as salvage therapy in refractory testicular cancer.Cancer Chemother: Pharmacol., 18, S45 (1986).
Droz, J. P., Pico, J. L., Kramar, A.: Role of autologous bone marrow transplantation in germ-cell cancer.Urol. Clin. North. Amer., 20, 161 (1993).
Sternberg, C. N.: Role of primary chemotherapy in stage I and low-volume stage II non-seminomatous germ-cell testis tumors.Urol. Clin. North. Amer., 20, 93 (1993).
Horwich, A., Norman, A., Fisher, C.: Primary chemotherapy for stage II nonseminomatous germ cell tumors of the testis.J. Urol., 151, 72 (1994).
Vugrin, D., Whitmore, W. F. Jr., Sogani, P. C.: Combined chemotherapy and surgery in treatment of advanced germ cell tumors.Cancer, 47, 2228 (1981).
Miki, T., Saiki, S., Kotake, T.: The role of salvage surgery following chemotherapy in advanced testicular cancer.Acta Urol. Jpn., 40, 951 (1994).
Murphy, B. R., Breeden, E. S., Donohue, J. P.: Surgical salvage of chemotherapy germ cell tumors.J. Clin. Oncol., 11, 324 (1993).
Vugrin, D., Whitmore, W. F.: The role of chemotherapy and surgery in the treatment of retroperitoneal metastases in advanced nonseminomatous testis cancer.Cancer, 55, 1874 (1985).
Fossa, S. D., Ous, S., Lien, H. H.: Post-chemotherapy lymph node histology in radiologically normal patients with metastatic nonseminomatous testicular cancer.J. Urol., 141, 557 (1989).
Toner, G. C., Panicek, D. W., Geller, N. L.: Adjunctive surgery after chemotherapy for nonseminomatous germ cell tumors: Recommendations for patient selection.J. Clin. Oncol., 8, 1683 (1990).
Sheinfeld, J., Bajorin, D.: Management of the postchemotherapy residual mass.Urol. Clin. North. Amer., 20, 133 (1993).
Logothetis, C. J., Samuels, M. L., Trindale, A.: The growing teratoma syndrome.Cancer, 50, 1629 (1982).
Nishimura, K., Segushi, T., Matsuda, M.: Mature teratoma of the testis metastasizing as mature teratoma: A case report.Nishinihon J. Urol., 52, 1471 (1990).
Herr, H. W., LaQuaglia, M. P.: Management of teratoma.Urol. Clin. North. Amer., 20, 145 (1993).
Steyerberg, E. W., Keizer, H. J., Stoter, G., Habbema, A.: Predictors of residual mass histology following chemotherapy for metastatic non-seminomatous testicular cancer: A quantitative overview of 996 resections.Eur. J. Cancer, 30A, 1231 (1994).
Loehrer, P. J., Hui, S., Clark, S., Seal, M., Einhorn, L. H., Williams, S. D., Ulbright, T., Mandelbaum, I., Rowland, R., Donohue, J. P.: Teratoma following cisplatin-based combination chemotherapy or nonseminomatous germ cell tumors: A clinicopathological correlation.J. Urol., 135, 1183 (1986).
Donohue, J. P., Rowland, R. G., Kopecky, K.: Correlation of computerized tomographic changes and histological findings in 80 patients having radical retroperitoneal lymph node dissection after chemotherapy for testis cancer.J. Urol., 137, 1176 (1987).
Fossa, S. D., Qvist, H., Stenwig, A. E.: Is postchemotherapy retroperitoneal surgery necessary in patients with nonseminomatous testicular cancer and minimal residual tumor masses.J. Clin. Oncol., 10, 569 (1992).
Javadpour, N., Young, J. D.: Predictors of residual mass requiring surgical resection after chemotherapy of stage III testicular cancer.Urology, 40, 7 (1992).
Motzer, R. J., Bosl, G. J., Geller, N. L.: Advanced seminoma: The role of chemotherapy and adjunctive surgery.Ann. Intern. Med., 108, 513 (1988).
Motzer, R., Bosl, G., Heelan, R.: Residual mass: An indication for further therapy in patients with advanced seminoma following systemic chemotherapy.J. Clin. Oncol., 5, 1064 (1987).
Motzer, R. J.: Optimal treatment for advanced seminoma.Cancer, 72, 3 (1993).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Suzuki, K., Kurokawa, K., Suzuki, T. et al. Metastatic testicular germ cell tumour: The role of salvage surgery. International Urology and Nephrology 30, 171–179 (1998). https://doi.org/10.1007/BF02550573
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF02550573